Dasatinib-Induced Pulmonary Arterial Hypertension

Am J Ther. 2020 Aug 3;28(6):e695-e696. doi: 10.1097/MJT.0000000000001213.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Dasatinib / adverse effects
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Protein Kinase Inhibitors / adverse effects
  • Pulmonary Arterial Hypertension*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Dasatinib